A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

NCT07310901 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Obese But Otherwise Healthy Participants

Interventions

DRUG: CRB-913
DRUG: Placebo

Sponsor

Corbus Pharmaceuticals Inc.